Dallas, Texas (PRWEB) January 11, 2013
The global contrast media market is broadly segmented into barium-based, iodinated and gadolinium-based contrast media. These products are further categorized based on the medical procedure (X-ray, CT, MRI, ultrasound, and catheterization laboratory), route of administration (oral, injection, rectal, and urethral), medical indication (cardiovascular, respiratory, musculoskeletal, gastrointestinal, and neurology, nephrology and oncology) and finally application (radiology, interventional radiology and interventional cardiology). The global contrast media market is worth $6.2 billion in 2012, and estimated to grow at a CAGR of 6.8% to reach $8.6 billion by 2017.
The global contrast media market, though fairly mature at present (2012), still shows potential to grow over the next five years. It is propelled by the increasing demand for diagnostic imaging and image guided surgical procedures, technological advances in diagnostic imaging and the ever-increasing incidence rates of cancer and cardiac disorders. However, major economies of the world undergoing healthcare reforms are the pivotal factors affecting the growth of the market and thereby affecting contrast media sales.
The U.S. represents the largest contrast media market worldwide, followed by Europe and Japan. However, the economic slowdown has augmented opportunities for emerging markets like India and China to strengthen their position in the global arena. Advances in medical technology coupled with huge foreign investments from developed nations, allows these emerging markets to compete with global market leaders in this segment. Investment firms are increasingly focusing on expansion in developing markets of Asia, Latin America and Eastern Europe, since the U.S. is on the brink of embracing healthcare reforms and major economies in Europe are still recovering from huge financial deficits.
The global marketplace is highly competitive, with several small players specific to a particular geography challenging major ones. Owing to the recession and the emerging opportunities in developing countries, many small companies have similar product offerings at competitive prices. Some of the major players profiled in this report are GE Healthcare (U.K.), Bracco Diagnostic, Inc. (Italy), Bayer Healthcare Pharmaceuticals (Germany), Covidien (Ireland) and Guerbet Group (France).
Contrast agents have evolved significantly over the past century, from barium and iodine-based agents that were used initially by medical practitioners and radiologists, to the more advanced agents like radiopharmaceuticals and gold nanoparticles that are currently in use. Sophisticated techniques such as targeted MRI imaging and gas microbubble technology in ultrasound will prove to be essential drivers in the widespread use of contrast agents in the future.
The scope of the report spans the global contrast media market which comprises:
Global Contrast Media Market, by Product
- Barium-based contrast media
- Iodinated contrast media
- Low-osmolar contrast media (LOCM)
- High-osmolar contrast media (HOCM)
- Gadolinium-based contrast media
Global Contrast Media Market, by Route of Administration
- Intravenous (I.V.)
- Intra-arterial (I.A.)
Global Contrast Media Market, by Medical Procedure
- Computed tomography (CT)
- Magnetic resonance imaging (MRI)
- Catheterization laboratory (cath lab)
Global Contrast Media Market, by Indication
- Cardiovascular disorders
- Neurological disorders
- Gastrointestinal disorders
- Respiratory diseases
- Musculoskeletal anomalies
- Nephrological disorders
- Oncology (tumor detection)
Global Contrast Media Market, by Application
- Interventional radiology
- Interventional cardiology
Contrast Media Market, by Geography
- United Kingdom (U.K.)
- Scandinavian countries (Sweden, Denmark, Finland, and Norway)
- Rest of Europe
- Rest of Asia-Pacific
Rest of the world (RoW)
- Latin America
- Middle East & Africa
Each section of the report offers market data for the various market segments and geographies. It also provides in-depth information on market trends with respect to drivers, restraints, opportunities and technology trends.
Buy a copy of report @ http://www.reportsnreports.com/purchase.aspx?name=214059 . Alternatively, Request A Sample @ http://www.reportsnreports.com/contacts/requestsample.aspx?name=214059 to help make your purchase decision.
Major Company Profiles: Amag Pharmaceuticals, Inc., Bayer Healthcare Pharmaceuticals, Bracco Imaging Spa (A Subsidiary Of Bracco S.P.A), Covidien, CMC Contrast AB, Daiichi Sankyo Co., Ltd., GE Healthcare, Genovis AB, Guerbet Group, Lantheus Medical Imaging, Inc., Nanopet Pharma Gmbh, Nanoscan Imaging, LLC, Sanochemia Pharmazeutika AG, Spago Imaging AB (A Subsidiary Of Accelerator Nordic Ab), Subhra Pharma Private, Ltd, Taejoon Pharm Co., Ltd., Targeson, Inc., Unijules Life Sciences, Ltd.
Browse more reports on Healthcare Market.
ReportsnReports.com (http://www.reportsnreports.com/ ) is an online market research reports library of 200,000+ in-depth studies of over 5000 micro markets. Our database includes reports by leading publishers from across the globe. We provide 24/7 online and offline support service to our customers.